A 74-year-old Caucasian man with hypertension and hereditary hemochromatosis presented with new onset atrial fibrillation. An echocardiogram (TTE) showed marked concentric hypertrophy with abnormally low global longitudinal strain (GLS) of -11.4% and apical sparing. Iron overload cardiomyopathy was ruled out by a cardiac MRI; however, diffuse late gadolinium uptake was suggestive of amyloid deposition. Serum immunofixation and free light chains were negative for AL amyloidosis. Wild-type (senile) transthyretin (ATTR) cardiac amyloidosis (CA) was suspected given patient's age. A 99m Tc-methylene diphosphate (MDP) bone scan was carried out; however, it did not show any cardiac uptake (Figures 1, 2 , Panel 1). Repeat imaging was performed using 99m Tc-pyrophosphate (PYP), which showed intense tracer uptake diffusely in the myocardium (Figures 1 and 2, Panel 2) .
CASES
A 74-year-old Caucasian man with hypertension and hereditary hemochromatosis presented with new onset atrial fibrillation. An echocardiogram (TTE) showed marked concentric hypertrophy with abnormally low global longitudinal strain (GLS) of -11.4% and apical sparing. Iron overload cardiomyopathy was ruled out by a cardiac MRI; however, diffuse late gadolinium uptake was suggestive of amyloid deposition. Serum immunofixation and free light chains were negative for AL amyloidosis. Wild-type (senile) transthyretin (ATTR) cardiac amyloidosis (CA) was suspected given patient's age. A 99m Tc-methylene diphosphate (MDP) bone scan was carried out; however, it did not show any cardiac uptake (Figures 1, 2 , Panel 1). Repeat imaging was performed using 99m Tc-pyrophosphate (PYP), which showed intense tracer uptake diffusely in the myocardium (Figures 1 and 2, Panel 2) .
A 79-year-old African-American woman with sarcoidosis presented with NYHA class III heart failure symptoms. TTE showed new severe eccentric LVH and severe global hypokinesis with EF 34%. Given the history of sarcoidosis, a cardiac MRI was obtained without evidence of cardiac sarcoidosis, but with diffuse late gadolinium enhancement suspicious for CA. Serumfree light chains and immunofixation were negative. Radionuclide bone scintigraphy was obtained first using 99m Tc-MDP, but the images were equivocal for tracer uptake in the myocardium ( Figures 3 and 4, Panel 3) . The patient was reimaged using 99m Tc-PYP which showed diffuse uptake in the myocardium ( Figures 3  and 4 , Panel 4), consistent with ATTR cardiac amyloidosis.
DISCUSSION
Radionuclide scintigraphy with technetium-labeled bisphosphonates is proposed as a reliable non-invasive strategy to diagnose ATTR cardiac amyloidosis.
1,2 A recent study reported similar diagnostic accuracy using 3 different radiotracers:
99m Tc-DPD (3,3-diphosphono-1,2-propanodicarboxylic acid), 99m Tc-HMDP (hydroxymethylene diphosphonate), and 99m Tc-PYP. 3 We present 2 cases of ATTR cardiac amyloidosis in which 99m Tc-MDP scintigraphy failed to show myocardial uptake. This suggests that 99m Tc-MDP lacks sensitivity for diagnosis of ATTR cardiac amyloidosis and should not be used in this setting. Tc-pyrophosphate (PYP) following planar scan with an uptake in bones and also diffuse myocardial uptake, more intense in the left ventricle.
